Skip to main content
Premium Trial:

Request an Annual Quote

Maverick Health to Offer Visby Medical Rapid Coronavirus Test

NEW YORK — Diagnostic testing services provider Maverick Health said on Friday that it has signed an agreement to offer Visby Medical's rapid point-of-care SARS-CoV-2 test.

The Visby Medical COVID-19 Point of Care Test is a single-use, fully integrated RT-PCR assay designed to detect SARS-CoV-2 nucleic acid, providing results within 30 minutes. It received Emergency Use Authorization from the US Food and Drug Administration in February for use with nasopharyngeal, anterior nasal, or mid-turbinate swabs collected by a health care provider or in anterior nasal or mid-turbinate swabs self-collected under the supervision of a healthcare provider. 

Under the terms of the agreement, Miami-based Maverick will provide the test to organizational partners, through its network of concierge testing sites in New York, Boston and Miami, and to customers for use at home.

Additional terms were not disclosed.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.